Haematology - HCP
Fabhalta iptacopan logo
FABHALTA®▼ (iptacopan)
Jakavi ruxolitinib logo
Haematology
JAKAVI® (ruxolitinib)
SCEMBLIX®▼ (asciminib) logo
Haematology
SCEMBLIX®▼ (asciminib)

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis online through the pharmacovigilance intake (PVI) tool at www.novartis.com/report, or alternatively email [email protected] or call 01276 698370.


Source URL: https://www.pro.novartis.com/uk-en/medicines/haematology